{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:33:06Z","timestamp":1772652786065,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JPC-7","award":["VP000262-O1"],"award-info":[{"award-number":["VP000262-O1"]}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-17-1-0584"],"award-info":[{"award-number":["W81XWH-17-1-0584"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012414","name":"Armed Forces Radiobiology Research Institute, Uniformed Services University","doi-asserted-by":"publisher","award":["RBB24402"],"award-info":[{"award-number":["RBB24402"]}],"id":[{"id":"10.13039\/100012414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012414","name":"Armed Forces Radiobiology Research Institute, Uniformed Services University","doi-asserted-by":"publisher","award":["ROB410978"],"award-info":[{"award-number":["ROB410978"]}],"id":[{"id":"10.13039\/100012414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["anim microbiome"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mammalian gut harbors very complex and diverse microbiota that play an important role in intestinal homeostasis and host health. Exposure to radiation results in dysbiosis of the gut microbiota leading to detrimental pathophysiological changes to the host. To alleviate the effects of irradiation, several candidate countermeasures are under investigation. BIO 300, containing synthetic genistein formulated as an amorphous solid dispersion or as an aqueous suspension of nanoparticles, is a promising candidate under advanced development. The aim of this study was to investigate the effects of BIO 300 on the gut microbiome and metabolome of mice exposed to <jats:sup>60<\/jats:sup>Co gamma-radiation. The gut microbiota and metabolome of control and drug-treated mice exposed to radiation was characterized by bacterial 16S rRNA amplicon sequencing and untargeted metabolomics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that irradiation altered the <jats:italic>Firmicutes<\/jats:italic>\/<jats:italic>Bacteroidetes<\/jats:italic> ratio and significantly decreased the relative abundance of <jats:italic>Lactobacillus<\/jats:italic>, both in BIO 300-treated and control mice; however, the ratio returned to near normal levels in BIO 300-treated mice by day 14 post-irradiation. Concomitantly, we also observed corrective shifts in metabolic pathways that were perturbed after irradiation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, the data presented show that radiation exposure led to a relative depletion of commensals like <jats:italic>Lactobacillus<\/jats:italic> leading to an inflammatory metabolic phenotype while the majority of the drug-treated mice showed alleviation of this condition primarily by restoration of normal gut microbiota. These results indicate that the radioprotective effects of BIO 300, at least in part, may involve correction of the host-microbiome metabolic axis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42523-021-00132-1","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:10:41Z","timestamp":1633896641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Microbiome study in irradiated mice treated with BIO 300, a promising radiation countermeasure"],"prefix":"10.1186","volume":"3","author":[{"given":"Amrita K.","family":"Cheema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Y.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluseyi O.","family":"Fatanmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Kaytor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-3849","authenticated-orcid":false,"given":"Vijay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"132_CR1","first-page":"105","volume":"5","author":"L Heslet","year":"2012","unstructured":"Heslet L, Bay C, Nepper-Christensen S. Acute radiation syndrome (ARS)\u2014treatment of the reduced host defense. Int J Gen Med. 2012;5:105\u201315.","journal-title":"Int J Gen Med"},{"key":"132_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/HP.0b013e318266ee13","volume":"103","author":"C Booth","year":"2012","unstructured":"Booth C, Tudor G, Tudor J, Katz BP, MacVittie TJ. Acute gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 2012;103:383\u201399.","journal-title":"Health Phys"},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/14656566.2019.1702968","volume":"21","author":"VK Singh","year":"2020","unstructured":"Singh VK, Seed TM. Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems. Expert Opin Pharmacother. 2020;21:317\u201337.","journal-title":"Expert Opin Pharmacother"},{"key":"132_CR4","volume-title":"Radiobiology for the radiobiologist","author":"EJ Hall","year":"2012","unstructured":"Hall EJ, Giaccia AJ. Radiobiology for the radiobiologist. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2012.","edition":"7"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s42399-018-0036-1","volume":"1","author":"DA Rodriguez","year":"2018","unstructured":"Rodriguez DA, V\u00e9lez RP, Monjaraz EMT, Jaime Ramirez-Mayans JR, Ryan PM. The gut microbiota: a clinically impactful factor in patient health and disease. SN Compr Clin Med. 2018;1:188\u201399.","journal-title":"SN Compr Clin Med"},{"key":"132_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-814330-8.00004-4","volume-title":"Adult short bowel syndrome","author":"GA Cresci","year":"2019","unstructured":"Cresci GA, Izzo K. Gut microbiome. In: Corrigan-KRaES ML, editor. Adult short bowel syndrome. 1st ed. New York: Academic Press; 2019. p. 45\u201354.","edition":"1"},{"key":"132_CR7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/B978-0-12-809954-4.00056-6","volume-title":"Physiology of the gastrointestinal tract","author":"PR Kiela","year":"2018","unstructured":"Kiela PR, Ghishan FK. Na+\/H+ exchange in mammalian digestive tract. In: Said-AeFKG HM, Kaunitz JD, Merchant JL, Wood JD, editors. Physiology of the gastrointestinal tract. 6th ed. New York: Academic Press; 2018. p. 1273\u2013316.","edition":"6"},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3389\/fmicb.2015.01050","volume":"6","author":"JE Belizario","year":"2015","unstructured":"Belizario JE, Napolitano M. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol. 2015;6:1050.","journal-title":"Front Microbiol"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1128\/aem.31.6.907-912.1976","volume":"31","author":"MA Harris","year":"1976","unstructured":"Harris MA, Reddy CA, Carter GR. Anaerobic bacteria from the large intestine of mice. Appl Environ Microbiol. 1976;31:907\u201312.","journal-title":"Appl Environ Microbiol"},{"key":"132_CR10","first-page":"26191","volume":"26","author":"S Carding","year":"2015","unstructured":"Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191.","journal-title":"Microb Ecol Health Dis"},{"key":"132_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2015.01.004","volume":"33","author":"YS Kim","year":"2015","unstructured":"Kim YS, Kim J, Park SJ. High-throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy. Anaerobe. 2015;33:1\u20137.","journal-title":"Anaerobe"},{"key":"132_CR12","doi-asserted-by":"publisher","first-page":"e82659","DOI":"10.1371\/journal.pone.0082659","volume":"8","author":"YD Nam","year":"2013","unstructured":"Nam YD, Kim HJ, Seo JG, Kang SW, Bae JW. Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing. PLoS ONE. 2013;8:e82659.","journal-title":"PLoS ONE"},{"key":"132_CR13","doi-asserted-by":"publisher","first-page":"13254","DOI":"10.1073\/pnas.0504830102","volume":"102","author":"PA Crawford","year":"2005","unstructured":"Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci USA. 2005;102:13254\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/gutjnl-2017-313789","volume":"67","author":"S Gerassy-Vainberg","year":"2018","unstructured":"Gerassy-Vainberg S, Blatt A, Danin-Poleg Y, Gershovich K, Sabo E, Nevelsky A, et al. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction. Gut. 2018;67:97\u2013107.","journal-title":"Gut"},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40168-017-0325-z","volume":"5","author":"D Casero","year":"2017","unstructured":"Casero D, Gill K, Sridharan V, Koturbash I, Nelson G, Hauer-Jensen M, et al. Space-type radiation induces multimodal responses in the mouse gut microbiome and metabolome. Microbiome. 2017;5:105.","journal-title":"Microbiome"},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/09553002.2017.1332438","volume":"93","author":"VK Singh","year":"2017","unstructured":"Singh VK, Seed TM. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. Int J Radiat Biol. 2017;93:851\u201369.","journal-title":"Int J Radiat Biol"},{"key":"132_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/09553002.2017.1338782","volume":"93","author":"VK Singh","year":"2017","unstructured":"Singh VK, Garcia M, Seed TM. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in large animals with or without FDA IND status. Int J Radiat Biol. 2017;93:870\u201384.","journal-title":"Int J Radiat Biol"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/09553002.2017.1332440","volume":"93","author":"VK Singh","year":"2017","unstructured":"Singh VK, Hanlon BK, Santiago PT, Seed TM. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with \u201cstandard of care\u201d medicinal and procedures not requiring regulatory approval for use. Int J Radiat Biol. 2017;93:885\u2013906.","journal-title":"Int J Radiat Biol"},{"key":"132_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/13543784.2020.1757648","volume":"29","author":"VK Singh","year":"2020","unstructured":"Singh VK, Seed TM. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure. Exp Opin Investig Drugs. 2020;29:429\u201341.","journal-title":"Exp Opin Investig Drugs"},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/ijms20051231","volume":"20","author":"AK Cheema","year":"2019","unstructured":"Cheema AK, Mehta KY, Santiago PT, Fatanmi OO, Kaytor MD, Singh VK. Pharmacokinetic and metabolomic studies with BIO 300, a nanosuspension of genistein, in a nonhuman primate model. Int J Mol Sci. 2019;20:1231.","journal-title":"Int J Mol Sci"},{"key":"132_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/jat.904","volume":"23","author":"MR Landauer","year":"2003","unstructured":"Landauer MR, Srinivasan V, Seed TM. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol. 2003;23:379\u201385.","journal-title":"J Appl Toxicol"},{"key":"132_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/09553000802317778","volume":"84","author":"TA Davis","year":"2008","unstructured":"Davis TA, Mungunsukh O, Zins S, Day RM, Landauer MR. Genistein induces radioprotection by hematopoietic stem cell quiescence. Int J Radiat Biol. 2008;84:713\u201326.","journal-title":"Int J Radiat Biol"},{"key":"132_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1269\/jrr.07121","volume":"49","author":"R Day","year":"2008","unstructured":"Day R, Barshishat-Kupper M, Mog S, McCart E, Prasanna P, Davis T, et al. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high dose total body irradiation. J Radiat Res. 2008;49:361\u201372.","journal-title":"J Radiat Res"},{"key":"132_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/09553000601132642","volume":"83","author":"TA Davis","year":"2007","unstructured":"Davis TA, Clarke TK, Mog SR, Landauer MR. Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. Int J Radiat Biol. 2007;83:141\u201351.","journal-title":"Int J Radiat Biol"},{"key":"132_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1667\/RR3326.1","volume":"180","author":"CT Ha","year":"2013","unstructured":"Ha CT, Li XH, Fu D, Xiao M, Landauer MR. Genistein nanoparticles protect mouse hematopoietic system and prevent proinflammatory factors after gamma irradiation. Radiat Res. 2013;180:316\u201325.","journal-title":"Radiat Res"},{"key":"132_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jrr\/rrz014","volume":"60","author":"MR Landauer","year":"2019","unstructured":"Landauer MR, Harvey AJ, Kaytor MD, Day RM. Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome. J Radiat Res. 2019;60:308\u201317.","journal-title":"J Radiat Res"},{"key":"132_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0921-8777(00)00069-0","volume":"485","author":"J Sierens","year":"2001","unstructured":"Sierens J, Hartley JA, Campbell MJ, Leathem AJ, Woodside JV. Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay. Mutat Res. 2001;485:169\u201376.","journal-title":"Mutat Res"},{"key":"132_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/tcm.10015","volume":"22","author":"J Sierens","year":"2002","unstructured":"Sierens J, Hartley JA, Campbell MJ, Leathem AJ, Woodside JV. In vitro isoflavone supplementation reduces hydrogen peroxide-induced DNA damage in sperm. Teratog Carcinog Mutagen. 2002;22:227\u201334.","journal-title":"Teratog Carcinog Mutagen"},{"key":"132_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.1232467","volume":"339","author":"SE Winter","year":"2013","unstructured":"Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013;339:708\u201311.","journal-title":"Science"},{"key":"132_CR30","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13:R79.","journal-title":"Genome Biol"},{"key":"132_CR31","doi-asserted-by":"publisher","first-page":"15701","DOI":"10.1038\/s41598-019-52120-w","volume":"9","author":"AK Cheema","year":"2019","unstructured":"Cheema AK, Li Y, Girgis M, Jayatilake M, Simas M, Wise SY, et al. Metabolomic studies in tissues of mice treated with amifostine and exposed to gamma-radiation. Sci Rep. 2019;9:15701.","journal-title":"Sci Rep"},{"key":"132_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/metabo10050211","volume":"10","author":"AK Cheema","year":"2020","unstructured":"Cheema AK, Li Y, Girgis M, Jayatilake M, Fatanmi OO, Wise SY, et al. Alterations in tissue metabolite profiles with amifostine-prophylaxed mice exposed to gamma radiation. Metabolites. 2020;10:211.","journal-title":"Metabolites"},{"key":"132_CR33","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council of the National Academy of Sciences","year":"2011","unstructured":"National Research Council of the National Academy of Sciences. Guide for the care and use of laboratory animals. 8th ed. Washington: National Academies Press; 2011.","edition":"8"},{"key":"132_CR34","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0969-8043(00)00052-X","volume":"52","author":"V Nagy","year":"2000","unstructured":"Nagy V. Accuracy considerations in EPR dosimetry. Appl Radiat Isot. 2000;52:1039\u201350.","journal-title":"Appl Radiat Isot"},{"key":"132_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581\u20133.","journal-title":"Nat Methods"},{"key":"132_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O\u2019Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779\u201387.","journal-title":"Anal Chem"},{"key":"132_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12859-015-0562-8","volume":"16","author":"G Libiseller","year":"2015","unstructured":"Libiseller G, Dvorzak M, Kleb U, Gander E, Eisenberg T, Madeo F, et al. IPO: a tool for automated optimization of XCMS parameters. BMC Bioinform. 2015;16:118.","journal-title":"BMC Bioinform"},{"key":"132_CR38","unstructured":"(NIST) NIoSaT (2017) NIST 2017 Tandem MS Library"},{"key":"132_CR39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ijrobp.2019.05.062","volume":"105","author":"IL Jackson","year":"2019","unstructured":"Jackson IL, Pavlovic R, Alexander AA, Connors CQ, Newman D, Mahmood J, et al. BIO 300, a nanosuspension of genistein, mitigates radiation-induced erectile dysfunction and sensitizes human prostate cancer xenografts to radiation therapy. Int J Radiat Oncol Biol Phys. 2019;105:400\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"132_CR40","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1111\/bph.14056","volume":"174","author":"IL Jackson","year":"2017","unstructured":"Jackson IL, Zodda A, Gurung G, Pavlovic R, Kaytor MD, Kuskowski MA, et al. BIO 300, a nanosuspension of genistein, mitigates pneumonitis\/fibrosis following high-dose radiation exposure in the C57L\/J murine model. Br J Pharmacol. 2017;174:4738\u201350.","journal-title":"Br J Pharmacol"},{"key":"132_CR41","doi-asserted-by":"publisher","first-page":"19343","DOI":"10.1038\/s41598-020-76494-4","volume":"10","author":"M Girgis","year":"2020","unstructured":"Girgis M, Li Y, Ma J, Sanda M, Wise SY, Fatanmi OO, et al. Comparative proteomic analysis of serum from nonhuman primates administered BIO 300: a promising radiation countermeasure. Sci Rep. 2020;10:19343.","journal-title":"Sci Rep"},{"key":"132_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7:1\u201314.","journal-title":"Microorganisms"},{"key":"132_CR43","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s11095-017-2200-9","volume":"34","author":"JW Jones","year":"2017","unstructured":"Jones JW, Jackson IL, Vujaskovic Z, Kaytor MD, Kane MA. Targeted metabolomics identifies pharmacodynamic biomarkers for BIO 300 mitigation of radiation-induced lung injury. Pharm Res. 2017;34:2698\u2013709.","journal-title":"Pharm Res"},{"key":"132_CR44","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S1470-2045(18)30095-0","volume":"19","author":"A Biragyn","year":"2018","unstructured":"Biragyn A, Ferrucci L. Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging. Lancet Oncol. 2018;19:e295\u2013304.","journal-title":"Lancet Oncol"},{"key":"132_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3233\/JAD-171151","volume":"63","author":"GM Pasinetti","year":"2018","unstructured":"Pasinetti GM, Singh R, Westfall S, Herman F, Faith J, Ho L. The role of the gut microbiota in the metabolism of polyphenols as characterized by gnotobiotic mice. J Alzheimers Dis. 2018;63:409\u201321.","journal-title":"J Alzheimers Dis"}],"container-title":["Animal Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42523-021-00132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42523-021-00132-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42523-021-00132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:14:54Z","timestamp":1633896894000},"score":1,"resource":{"primary":{"URL":"https:\/\/animalmicrobiome.biomedcentral.com\/articles\/10.1186\/s42523-021-00132-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1186\/s42523-021-00132-1","relation":{},"ISSN":["2524-4671"],"issn-type":[{"value":"2524-4671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed according to a protocol approved by Uniformed Services University Institutional Animal Care and Use Committee (IACUC). Research was conducted according to the <i>Guide for the Care and Use of Laboratory Animals.<\/i>","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Michael D. Kaytor is the Vice President of Research and Development of Humanetics Corporation, Edina, MN. The other authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}